Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 821 results for "hcv"

Research and Markets Adds Report: North American Automotive Pr...

Research and Markets has announced the addition of the "North American Automotive Production Outlook to 2018 by Vehicle Type, Fuel Type and Key Country Level Markets" report to its offerings. In a release, Research and Markets noted that report ..., 4 hours ago

154 images for hcv

Bangalore Mirror, 2 days ago
MedIndia, 3 days ago
Medical News Today, 2 days ago
OnMedicanet, 1 day ago
Bio-Medicine, 1 day ago
Project Inform, 4 days ago
Science Daily, 6 days ago
Greenpeace UK, 6 days ago
Aidsmap, 1 week ago
Aidsmap, 1 week ago

HCV genotype 1 most prevalent worldwide with 83.4 million cases

Hepatitis C virus genotype 1 is the most prevalent with 83.4 million infections accounting for 46.2% of all cases worldwide, according to new research data. While the HCV [ hepatitis C virus ] infection rate is decreasing in developed countries, ...
 Orthopedics Today11 hours ago Lifestyle impacts likelihood of developing metabolic syndrome in childhood cancer survivors  News-Medical.Net2 days ago Researchers provide global genotype prevalence estimates for HCV  News-Medical.Net2 days ago Study Identifies Hepatitis C Virus Genotype 1 as the Most Prevalent Worldwide  MedIndia1 day ago

Automotive Steering Systems Market worth $32.4 Billion by 2018

/PRNewswire/ -- The report " Automotive Steering System Market by Vehicle Type (Passenger Car, LCV, & HCV), System Type (Manual, HPS, EHPS & EPS), Safety Features (With ABS/ESP & Without ABS/ESP), & Geography - Industry Trends & Forecast to 2018 ...
 Crawford Financial Planning19 hours ago "Automotive Suspension Systems Market - Industry Trends & Forecast to 2018" Is Now Available at Fast Market Research  Market Pulse Navigator4 days ago

Antiretroviral therapy may also treat hepatitis C

[Photo/IC] An antiretroviral therapy for HIV can also treat hepatitis C virus (HCV) in patients co-infected with HIV and hepatitis C, a small study said Wednesday. Researchers from University of Cincinnati and elsewhere studied the two-year ...
 CHINAdaily2 days ago Improvement of kidney function after anti HCV therapy in hepatitis C/HIV coinfection  National AIDS Treatment Advocacy Project1 day ago 3D Hepatitis C Combo Effective in HIV Patients  EverydayHealth.com1 day ago New therapies for HCV create better alternatives for patients  Orthopedics Today1 day ago

CV sales to improve Q2 onwards; to cut costs: Ashok Leyland

Commercial vehicle major Ashok Leyland sees sales of its medium and heavy commercial vehicles (M&HCV) improving from the second quarter of this financial year, the company told analysts in a conference call to discuss first quarter earnings. The ...
 Moneycontrol.com2 days ago Ashok Leyland Q1 turnover up 5%  India Infoline2 days ago Ashok Leyland sales climb 7% in June  Myiris4 weeks ago Ashok Leyland sales drop 9% in May  Myiris1 month ago

Market Ignores AbbVie's Impressive Sales Due To Reliance On Humira

Summary AbbVie posts solid second quarter results. After the Shire acquisition, all eyes are on the anticipated HCV launch later this year. Success is required in HCV and the remaining pipeline to tackle the upcoming expiration of Humira in 2016.
 Seeking Alpha4 days ago AbbVie Q2 Earnings Top on Humira Sales, Shire…  Zacks.com4 days ago AbbVie Earnings Take Back Seat to Shire Merger  24/7 Wall St4 days ago

Gilead Crushes Q2 Earnings Estimates as Sovaldi Sales Soar

There is no holding back Gilead Sciences ( GILD ) hepatitis C virus (:HCV) drug Sovaldi. The drug continued its exceptional performance in the second quarter of 2014, helping the company to beat the Zacks Consensus Estimate on both revenues and ...
 Yahoo! Finance5 days ago Gilead Reaps $3.48 Billion in Second Quarter Sovaldi Sales  AIDSmeds6 days ago Merck (MRK) Tops Q2 Earnings Expectations on Cost Cuts  Yahoo! Finance18 hours ago Hepatitis C Patients Recognize Benefits Of Super Expensive Solvaldi  Medical Daily5 days ago

Liver transplantation

Sarala Devi M (41), a resident of Govindrajanagar, who is suffering from HCV-related cirrhosis, needs liver transplantation. The estimated cost for the liver transplant is Rs 29,00,000. She is currently undergoing treatment at BGS Global Hospitals.
 Deccan Herald1 week ago

Efficacy and Safety of Dolutegravir (DTG) in Hepatitis (HBV or HCV) Co-infected Patients: Results From the Phase 3 Program

20th International AIDS Conference July 20-25, 2014 Melbourne, Australia Reported by 20th International AIDS Conference; July 20-25, 2014; Melbourne, Australia S Min,1 J Roberts,2 S Almond,2 L Curtis,3 C Stainsby,3 J Lim,4 B Wynne,5 G Nichols1 ...
 National AIDS Treatment Advocacy Project1 day ago Phase 2 COSMOS study results show efficacy & safety of Janssen's once-daily simeprevir in all oral 12-week combo with sofosbuvir for genotype 1 chronic hepatitis C  PharmaBiz21 hours ago Phase 2 COSMOS study results published in The Lancet demonstrate efficacy and safety of Janssen's once-daily imeprevir  European Pharmaceutical Review18 hours ago Medivir: Phase II COSMOS Study Results Published in The Lancet on World Hepatitis Day  Scottrade2 days ago

Doctor Evidence Partnering with Healthcare Decision-Makers on Hepatitis C Evidence

Doctor Evidence, LLC has developed a comprehensive database of clinical evidence in Hepatitis C (HCV) to address the evolving needs of healthcare stakeholders. Santa Monica, CA (PRWEB) July 29, 2014 Doctor Evidence (DRE), the Santa Monica, ...
 Benzinga.com1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less